Back
Syndax Pharmaceuticals Stock Price Chart

How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.
Sell
30
SNDX
Syndax Pharmaceuticals
Last Price:
12.94
Seasonality Move:
15.76%
7 Day Trial
ALL ACCESS PASS
$
7

FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing selling pressure, which indicates risk of future bearish movement.
Syndax Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.1 | Sell |
20-day SMA: | 15.55 | Sell |
50-day SMA: | 17.53 | Sell |
200-day SMA: | 20.14 | Sell |
8-day EMA: | 14.18 | Sell |
20-day EMA: | 15.37 | Sell |
50-day EMA: | 16.93 | Sell |
200-day EMA: | 19.14 | Sell |
Syndax Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.15 | Sell |
Relative Strength Index (14 RSI): | 27.84 | Sell |
Chaikin Money Flow: | -1898565 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.46 - 16.9) | Sell |
Bollinger Bands (100): | (16.52 - 20.66) | Sell |
Syndax Pharmaceuticals Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Syndax Pharmaceuticals Stock
Is Syndax Pharmaceuticals Stock a Buy?
- Syndax Pharmaceuticals share price is 13.24 while SNDX 8-day simple moving average is 14.10, which is a Sell signal.
- The stock price of SNDX is 13.24 while Syndax Pharmaceuticals 20-day SMA is 15.55, which makes it a Sell.
- Syndax Pharmaceuticals 50-day simple moving average is 17.53 while SNDX share price is 13.24, making it a Sell technically.
- SNDX stock price is 13.24 and Syndax Pharmaceuticals 200-day simple moving average is 20.14, creating a Sell signal.
SNDX Technical Analysis vs Fundamental Analysis
Sell
30
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy or a Sell?
-
Syndax Pharmaceuticals stock is rated a Sell
The current Syndax Pharmaceuticals [SNDX] share price is $13.24. The Score for SNDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Syndax Pharmaceuticals Stock Info
Market Cap:
1.13B
Price in USD:
13.24
Share Volume:
3.25M
Syndax Pharmaceuticals 52-Week Range
52-Week High:
25.34
52-Week Low:
13.26
Sell
30
Syndax Pharmaceuticals (SNDX)
is a Sell
Syndax Pharmaceuticals Share Price Forecast
-
What is the Syndax Pharmaceuticals stock price today?
The Syndax Pharmaceuticals stock price is 13.24 USD today. -
Will SNDX stock go up or go down?
Syndax Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Syndax Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Syndax Pharmaceuticals is overvalued.
Is Syndax Pharmaceuticals Stock a Buy?
- Syndax Pharmaceuticals share price is 13.24 while SNDX 8-day exponential moving average is 14.18, which is a Sell signal.
- The stock price of SNDX is 13.24 while Syndax Pharmaceuticals 20-day EMA is 15.37, which makes it a Sell.
- Syndax Pharmaceuticals 50-day exponential moving average is 16.93 while SNDX share price is 13.24, making it a Sell technically.
- SNDX stock price is 13.24 and Syndax Pharmaceuticals 200-day simple moving average is 19.14, creating a Sell signal.
Fundamental Analysis of Syndax Pharmaceuticals
Is Syndax Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $1.44 per share.
Technical Analysis of Syndax Pharmaceuticals
Should I short Syndax Pharmaceuticals stock?
- SNDX Moving Average Covergence Divergence (MACD) indicator is -1.15, suggesting Syndax Pharmaceuticals is a Sell
- Syndax Pharmaceuticals Relative Strength Index (RSI) is 27.84, which suggest Syndax Pharmaceuticals is oversold
- The Bollinger Bands (25) for Syndax Pharmaceuticals is (14.46 - 16.9), which suggest Syndax Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Syndax Pharmaceuticals is (16.52 - 20.66), which suggest Syndax Pharmaceuticals is a Sell
* Syndax Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.